Zynerba Pharmaceuticals Inc (ZYNE)

Currency in USD
1.300
0.000(0.00%)
Closed·
Showing Zynerba Pharma historical data. For real-time data please try another search
Day's Range
1.2601.340
52 wk Range
1.2601.340
Key Statistics
Prev. Close
1.3
Open
1.26
Day's Range
1.26-1.34
52 wk Range
1.26-1.34
Volume
-
Average Volume (3m)
1.12M
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Zynerba Pharmaceuticals Inc Company Profile

Harmony Biosciences Management, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. Harmony Biosciences Management, Inc. was formerly known as Zynerba Pharmaceuticals, Inc. and changed its name Harmony Biosciences Management, Inc. in July 2024. Harmony Biosciences Management, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania. As of October 10, 2023, Harmony Biosciences Management, Inc. operates as a subsidiary of Harmony Biosciences Holdings, Inc.

Earnings

Latest Release
Nov 13, 2023
EPS / Forecast
-- / -0.20
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ZYNE Income Statement

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.